成人登革热发热期可溶性尿激酶纤溶酶原激活物受体与嗅质蛋白4作为重症登革热预后生物标志物
研究前瞻性纳入99例成人登革热患者(40例登革热、46例登革热伴预警信号、13例重症登革热)和30例对照,在发热期、极期和恢复期检测血浆可溶性尿激酶纤溶酶原激活物受体(suPAR)、嗅质蛋白4、糜酶和类胰蛋白酶。发热期suPAR预测重症登革热的AUROC为0.82,以5.4 ng/mL为切点、按本医疗机构重症登革热估计患病率16.5%计算,灵敏度71.4%、特异度87.9%,阳性预测值54.7%、阴性预测值95.8%。作者认为suPAR可能是成人登革热发热期预测重症登革热的可靠预后生物标志物。
要点
- 发热期suPAR预测重症登革热的AUROC为0.82。
- 切点5.4 ng/mL时灵敏度71.4%、特异度87.9%,阳性预测值54.7%、阴性预测值95.8%。
- 嗅质蛋白4在登革热患者中升高,但发热期未随疾病严重程度成比例升高(P = .04)。
核心结论
- 在成人登革热中,suPAR可能是发热期预测重症登革热的可靠预后生物标志物。
研究设计与样本
- 前瞻性纳入99例成人登革热患者(40例登革热、46例登革热伴预警信号、13例重症登革热)及30例对照。
- 在登革热患者的发热期、极期和恢复期检测血浆suPAR、嗅质蛋白4、糜酶和类胰蛋白酶水平。
主要发现
- 重症登革热患者的suPAR水平在发热期(P < .001)、极期(P < .001)和恢复期(P = .005)均显著高于其他登革热严重程度组和对照组。
- 发热期suPAR预测重症登革热的AUROC为0.82。
- 以Youden指数得出的切点5.4 ng/mL、按本医疗机构重症登革热估计患病率16.5%计算,发热期灵敏度为71.4%、特异度为87.9%,阳性预测值和阴性预测值分别为54.7%和95.8%。
- 嗅质蛋白4在登革热患者中升高,但发热期未随疾病严重程度成比例升高(P = .04)。
- 糜酶和类胰蛋白酶水平在登革热患者与对照组之间无显著差异。
关键数值与推荐
- 发热期suPAR切点5.4 ng/mL(由Youden指数得出),按本医疗机构重症登革热估计患病率16.5%计算,灵敏度71.4%、特异度87.9%、阳性预测值54.7%、阴性预测值95.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dengue cases continue to rise and can overwhelm healthcare systems during outbreaks. In dengue, neutrophil mediators, soluble urokinase plasminogen activator receptor (suPAR) and olfactomedin 4, and mast cell mediators, chymase and tryptase, have not been measured longitudinally across the dengue phases. The utility of these proteins as prognostic biomarkers for severe dengue has also not been assessed in an older adult population. METHODS: We prospectively enrolled 99 adults with dengue-40 dengue fever, 46 dengue with warning signs and 13 severe dengue, along with 30 controls. Plasma levels of suPAR, olfactomedin 4, chymase and tryptase were measured at the febrile, critical and recovery phases in dengue patients. RESULTS: The suPAR levels were significantly elevated in severe dengue compared to the other dengue severities and controls in the febrile (P < .001), critical (P < .001), and recovery (P = .005) phases. In the febrile phase, suPAR was a prognostic biomarker of severe dengue, with an AUROC of 0.82. Using a cutoff derived from Youden's index (5.4 ng/mL) and an estimated prevalence of severe dengue (16.5%) in our healthcare institution, the sensitivity was 71.4% with a specificity of 87.9% in the febrile phase, and the positive and negative predictive values were 54.7% and 95.8%, respectively. Olfactomedin 4 was elevated in dengue patients but not in proportion to disease severity in the febrile phase (P = .04) There were no significant differences in chymase and tryptase levels between dengue patients and controls. CONCLUSIONS: In adult dengue, suPAR may be a reliable prognostic biomarker for severe dengue in the febrile phase.
引用
- Teo A, Le CTT, Tan T, et al. Febrile Phase Soluble Urokinase Plasminogen Activator Receptor and Olfactomedin 4 as Prognostic Biomarkers for Severe Dengue in Adults. Clin Infect Dis. 2024. PMID: 37823481. doi:10.1093/cid/ciad637
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。